Vaccines - STAT

Health By Matthew Herper

DISTANCED: Pandemic stories of Black life in the rural South

Health By Andrew Joseph

What will the Covid-19 booster rollout look like? Public health groups plan as they await details

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

Pharmalot By Casey Ross

Pharmalittle: FDA scientists skeptical on boosters; moderate Democrats sink Pelosi’s drug pricing proposal

Health By Matthew Herper and Helen Branswell

FDA scientists strike skeptical tone on need for Covid-19 vaccine booster at this time, likely fueling debate

Health By Helen Branswell

A conversation with Bill Gates on how public health has fared in the midst of the pandemic

Health By Helen Branswell

A vaccine veteran steps away from the NIH, looking out toward the world

Health By Elizabeth Cooney

Any qualms about an extra Covid vaccine dose? STAT readers respond

Health By Andrew Joseph

How the Delta variant’s remarkable ability to replicate threw new twists into the Covid-19 pandemic

Biotech By Matthew Herper

Moderna turns to biotech startup to ramp up Covid vaccine manufacturing

Health By Helen Branswell

CEPI warns of major hurdle to developing new Covid-19 vaccines and studying best booster approaches

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

Health By Helen Branswell

The debate over Covid-19 vaccine boosters, what to call them, and whether they’re needed

Health By Andrew Joseph

Vaccination reduces risk of long Covid, even when people are infected, U.K. study indicates

First Opinion By James Kwak, John Aloysius Cogan Jr. and Peter Siegelman

Two insurance-based ways to get more Americans vaccinated

polio vaccine administered ivory coast africa

First Opinion By Matshidiso Moeti

Africa has a chance to help the world end polio for good. It needs to seize it now

Exclusive By Olivia Goldhill

Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist

First Opinion By Craig Idlebrook

I was once a hardcore anti-vaxxer. Now I try to nudge people to get the Covid-19 vaccine

Health By Theresa Gaffney

‘Tired of worrying’: As some parents press for vaccines off-label, pediatricians call for patience

The Readout LOUD By Damian Garde and Meg Tirrell

Listen: Vaccine mandates, biotech’s messy summer, & a pharmaceutical thriller

Health By Helen Branswell

Covid-19 vaccines flirted with perfection at first. Reality is more complicated

Health By Andrew Joseph

Most Read

Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson

Tracking the FDA advisory panel meeting on Covid-19 booster shots

FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says

Winter is coming, again: What to expect from Covid-19 as the season looms

FDA vaccine regulators argue against Covid-19 vaccine boosters in new international review

How the risk of side effects could change with Covid-19 vaccine boosters

With science and scripture, a Baltimore pastor is fighting Covid-19 vaccine skepticism

All Coverage

Johnson & Johnson says additional dose boosts Covid vaccine efficacy

A community pioneer lost, and remembered

The Guardian of the Glades

DISTANCED: Pandemic stories of Black life in the rural South

What will the Covid-19 booster rollout look like? Public health groups plan as they await details

Listen: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

Pharmalittle: FDA scientists skeptical on boosters; moderate Democrats sink Pelosi’s drug pricing proposal

FDA scientists strike skeptical tone on need for Covid-19 vaccine booster at this time, likely fueling debate

A conversation with Bill Gates on how public health has fared in the midst of the pandemic

A vaccine veteran steps away from the NIH, looking out toward the world

Any qualms about an extra Covid vaccine dose? STAT readers respond

How the Delta variant’s remarkable ability to replicate threw new twists into the Covid-19 pandemic

Moderna turns to biotech startup to ramp up Covid vaccine manufacturing

CEPI warns of major hurdle to developing new Covid-19 vaccines and studying best booster approaches

Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

The debate over Covid-19 vaccine boosters, what to call them, and whether they’re needed

Vaccination reduces risk of long Covid, even when people are infected, U.K. study indicates

Two insurance-based ways to get more Americans vaccinated

Africa has a chance to help the world end polio for good. It needs to seize it now

Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist

I was once a hardcore anti-vaxxer. Now I try to nudge people to get the Covid-19 vaccine

‘Tired of worrying’: As some parents press for vaccines off-label, pediatricians call for patience

Listen: Vaccine mandates, biotech’s messy summer, & a pharmaceutical thriller

Covid-19 vaccines flirted with perfection at first. Reality is more complicated

As Delta spread, Covid-19 vaccine effectiveness against infection fell from 90% to 66% in one key study